Evidence map›Paper›PMID 11021594›Full record

ArticleGene therapy2000

Cotransduction of nondividing cells using lentiviral vectors.

K Frimpong, S A Spector

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy.Archivum immunologiae et therapiae experimentalis · 2023
    Review
  6. Article
  7. In Situ Programming of CAR T Cells.Annual review of biomedical engineering · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K FrimpongDepartment of Pediatrics, University of California, La Jolla 92093-0672, USA.
S A Spector
APLA Health · USUniversity of California, San Diego · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
PEDIATRIC AIDS--FACTORS IN TRANSMISSION AND PATHOLOGYR01AI039004 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SPECTOR, STEPHEN A · 1995 to 2005
$1.5M
NIAID NIH HHS AI-36214NIAID NIH HHS AI-39004
6 · The paper itself

Abstract

Diseases such as AIDS and cancers may require the introduction of multiple genes into either stem cells or nondividing cells, among others, for therapeutic purposes. Such genes may act at different points of the disease pathway, or may constitute a regulatory loop to bypass or rectify the defective gene or pathway underpinning the disease. Ideally, the therapeutic genes must be transduced together in diverse combinations, and the introduction should occur without constraints. Since lentiviral vectors can transduce both dividing and nondividing cells, they are ideal vehicles to investigate combinatorial gene transfer into diverse cells. In this study, we demonstrate that by using two independent lentiviral vectors, pseudotyped with the protein g of vesicular stomatitis virus, up to four genes can be introduced simultaneously into single dividing and nondividing cells. Up to 45% and 73% of dividing and nondividing cells, respectively, could be transduced with two lentiviral vectors. The efficiency of cotransducing a single cell was the product of the individual transduction efficiencies and suggested the absence of viral interference. Multiple and combinatorial gene transduction using lentiviral vectors may prove useful in gene therapy.

Indexed as

Genetic VectorsStem CellsActinsBacterial ProteinsCell LineDNA-Binding ProteinsFlow CytometryFluorescent DyesGene ExpressionGenetic EngineeringGenetic TherapyHeLa CellsHIV-1HumansLim KinasesLuminescent ProteinsActinsBacterial ProteinsDNA-Binding ProteinsFluorescent DyesLIMK1 protein, humanLim KinasesLuminescent ProteinsProtein KinasesProtein Serine-Threonine Kinasesyellow fluorescent protein, Bacteria

Identifiers

PMID11021594
OpenAlexW1988852350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.